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Summary.-In 1974, the National Institute for Biological Standards and Control
(NIBSC) established the first British Standard for carcinoembryonic antigen (CEA)
for use in comparative quantitative assays. The Standard, which was prepared
from material processed by the Chester Beatty Research Institute, is in the form
of a freeze-dried powder, sealed in all-glass ampoules code labelled 73/601 and
containing pure dry nitrogen. For practical purposes, each ampoule contains 100
units of CEA activity.
GOLD and Freedman (1965) described
a carcinoembryonic antigen (CEA) in
association with human gastrointestinal
tumours. Concentrations ofCEA in serum
are higher than normal in some patients
with malignant tumours of the bowel,
particularly colorectal carcinoma, and in
certain other conditions (Thomson et al.,
1969). The chemical study of this glyco-
protein was first reported by Krupey,
Gold and Freedman (1967).
Estimates of the concentration, in
ng/ml, of CEA in given samples of serum
vary between laboratories; this variation
is due in part to differences between the
reference antigens used by laboratories.
It was agreed that the provision of a
standard for CEA should increase the
homogeneity of results between labora-
tories and should make results from
different laboratories more directly com-
parable (Anderson, Laurence and Neville,
1973). Such a standard has now been
prepared and it falls into the class of
standards, commonly encountered in
biological work, for which there is no
generally accepted physical or chemical
definition of unitage; the unitage is
therefore defined by the standard itself.
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PREPARATION AND TESTING OF SOURCE
MATERIAL (CODED 2/22J)
(i) Preparation
The source material for the Standard
was prepared following, in part, the
method of Krupey et al. (1968) from an
autopsy liver metastasis arising from a
primary carcinoma of the sigmoid colon
(Turberville et al., 1973).
A perchloric acid extract of the
tumour material was made, dialysed
against distilled water and freeze-dried,
reconstituted, centrifuged and purified
by column chromatography on Sepha-
rose 4B and then on Sephadex G-200.
The block electrophoresis step suggested
by Krupey et al. (1968) was not used.
Altogether, a total of 376 mg of CEA
preparation 2/22J was obtained from
approximately 2 kg (wet weight) of
tumour.
(ii) Radioimmunoassay
Radioimmunoassay was performed by
a double antibody method (Laurence et al.,
1972) using a CEA preparation from
Montreal (through the courtesy of Dr
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The Montreal General Hospital, Quebec,
Canada) both as local standard and for
labelling, and goat anti-CEA and horse
anti-goat IgG from Duarte (through the
courtesy of Dr C. W. Todd, City of Hope
National Medical Center, Duarte, Cali-
fornia, U.S.A.). Preparation 2/22J had
an activity per mg of 104% of that of the
Montreal local standard when evaluated
by this method. Preparation 2/22J was
then adopted for use as a local standard
and as antigen for radioiodination in the
radioimmunoassay test at the Chester
Beatty Research Institute (CBRI).
(v) Amino acid composition
The amino acid composition of pre-
paration 2/22J (Table I) was determined
after hydrolysis in 6 N HCI at 100°C
for 24 h, using a Jeol autoanalyser. No
correction for hydrolytic loss was applied.
The amino acid composition of 2122J is
similar to the composition of purified
preparations of CEA reported by Banjo
et al. (1972) and Terry et al. (1972).
The N-terminal amino acid, deter-
mined by the micro-dansyl method, was
found to be lysine.
(iii) Examination by immunodiffusion
Double diffusion tests were made
against anti-CEA antisera and against a
rabbit antiserum with specifications dis-
cussed by Darcy, Turberville and James
(1973). The rabbit antiserum which
reacted with both CEA and CCEA-2
(CEX) (colonic carcinoembryonic anti-
gen-2) (Darcy et al., 1973) gave a single
precipitin line, no CCEA-2 line being
detectable in the case of the rabbit anti-
serum.* No reaction was observed with
antiserum known to react with CCEA-2.
An unabsorbed antiserum to a crude
perchloric acid extract of secondary colon
carcinoma, which reacted with components
of normal colon extract as well as with
CEA, gave only the CEA line when
subjected to a double diffusion test
against preparation 2/22J.
(iv) Examination by polyacrylamide gel
electrophoresis
This examination, in 20% polyacryl-
amide gel in acetic acid at pH 2-4, gave
a single band. Under these conditions
CCEA-2 is well separated from CEA
(Turberville et al., 1973) but a CCEA-2
band was not detected in preparation
2/22J.
* CCEA-2 has also been designated " NCA"
(nonspecific cross-reacting antigen) (von Kleist,
Chavanel and Burtin, 1972) and " NGP " (normal
glycoprotein) (Mach and Pusztaszeri, 1972).
TABLE I.--Amino Acid Composition of
CEA Preparation 2/22J
Asp
Thr
Ser
Glu
Pro
Gly
Ala
V7al
Cys/2
Met
Ile
Leu
Tyr
Phe
Lys
His
Arg
Cystine includes cysteic
detected as the sulphoxide.
mol/l00 mol
14-8
9 7
10-4
10-9
8-7
5-5
6-3
7-4
0 9
0-1 4.3
7-7
3-4
2 1
2-9
1*7
3 2
acid; methionine was
(vi) Carbohydrate composition
The monosaccharide composition
(Table II) was determined by a gas liquid
chromatographic method (Clamp, Bhatti
and Chambers, 1971). Sialic acid content
was determined by the method of Warren
(1959). The total carbohydrate content,
estimated from the recovery of mono-
saccharides, was approximately 60%.
The preparation differed from those des-
cribed by Mach and Pusztaszeri (1972) and
Banjo et al. (1972) in having higher fucose
and lower sialic acid content. However,
in these respects it was similar to other
CEA preparations produced at the Chester
Beatty Research Institute. The differ-
ences in analyses reported may reflectFIRST BRITISH STANDARD FOR CARCINOEMBRYONIC ANTIGEN (CEA)
TABLE II. Monosaccharide Composition of
CEAPreparation 2/22J
(Westwood, et al., 1974)
Fucose
Mannose
Galactose
GalNAc
GlcNAc
Sialic acids
differences in techni(
differences in materia
mol/100 mol
monosaccharides
20-4
17-4
24-0
0
37-8
3 6
que rather than real
no significant loss of CEA activity (esti-
mated as antigen by radioimmunoassay)
immediately after freeze drying or after
storage of the freeze-dried material at
37°C for 4 months. Dose-response lines
in a radioimmunoassay of the preparation
and 2 other samples of colonic CEA were
parallel.
The ampouled and freeze-dried
material was coded 73/601 and designated
as the First British Standard for Carcino-
embryonic Antigen (CEA).
(vii) Blood group activity
The material was tested in Lausanne
by Dr J.-P. Mach and found to be devoid
of major blood group cross-reacting acti-
vity as measured by a binding assay
against hyperimmune human plasma.
(viii) Contamination and potency
We have not detected significant
contamination in the CEA sample used
for the standard and have not assayed a
sample of higher potency relative to
initial weight taken.
AMPOULING AND PRELIMINARY
TESTING OF THE BRITISH STANDARD
Ampouling and freeze drying of pre-
paration 2/22J were carried out by Dr P.
J. Campbell and his staff at NIBSC.
51 mg were dissolved and diluted to an
estimated concentration of 20 ,ug/ml in a
solution of 0.5% lactose in distilled water,
filtered and filled into approximately
4000 ampoules in a volume of 0 5 ml per
ampoule. During the fill the wet weight
of contents was estimated on 68 ampoules.
The mean wet weight was 0 505 g with a
total variation of ±0-5%. The ampoule
contents were freeze dried and secondarily
dried to constant weight and sealed by
fusion of the glass so as to contain an
atmosphere of pure dry nitrogen. Pre-
liminary studies at the CBRI indicated
POTENCY ASSAYS
The estimated weight of freeze-dried
material (including lactose) in each
ampoule was 2-36 mg and a unitage was
assigned so that one unit of activity was
present in 0-0236 mg of the freeze-dried
powder, which of course was mostly
lactose. For practical purposes, each
ampoule of the British Standard contains
100 u of CEA activity. The powder
cannot be considered to be homogeneous
within each ampoule. Therefore, portions
of the powder should not be removed and
weighed, but the whole contents of the
ampoule should be dissolved in one
solution.
When a test sample of CEA is assayed
against the Standard, the immuno-
reactive content (or potency) of the test
sample should be expressed in terms of
units per ml of solution for liquid samples
or per mg of powder for dry samples.
Potency can be expressed most precisely
in these terms. Estimates of the mass of
" pure " CEA in one unit have yet to be
agreed upon, but such estimates will
inevitably vary between laboratories and
even between different assays in one
laboratory, thus leading to imprecision
of any finally accepted figure. It is
therefore much less precise to express
activity of CEA in terms of mass. (Mean
values of between 0-098 and 0-124 ,ug
of " pure " CEA (i.e. ofpreparation 2/22J)
per unit were obtained in preliminary
radioimmunoassays at the CBE'I.)
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INTERNATIONAL COLLABORATIVE STUDY
The First British Standard for CEA
is to be subjected to an extensive inter-
national collaborative study in a dozen
or so laboratories in a number ofcountries.
This study should assess the comparability
ofthe British Standard with CEA prepara-
tions from other sources, determine the
stability of the Standard after storage at
various elevatedtemperaturesfor6months
or more and give an estimate of the
number of micrograms of " pure " CEA
per unit of activity of the Standard.
A common antibody preparation will be
sent to participating centres to be used
alongside the local antibody in an attempt
to evaluate the role ofantibody specificity
in the assay.
RECOMMENDATIONS FOR THE USE OF
THE STANDARD
1. The Standard should be stored at
-20°C in the dark.
2. The contents of each ampoule of the
Standard should be reconstituted by the
addition of 0 5 ml of distilled water. The
powder should dissolve readily and com-
pletely on standing at room temperature.
This solution will for practical purposes
contain 100units of CEA activity. No
attempt should be made to weigh out
portions of the freeze-dried plug, which
cannot be assumed to be homogeneous.
3. CEA in a test sample should be assayed
against the standard or other calibrated
preparations by techniques which will
permit a valid statistical evaluation of
results, e.g. by a 6-point dose-response
regression analysis (Finney, 1964).
4. The relative potency of the test sample
should be expressed as units of immuno-
reactivity of CEA per ml of test solution
or per mg of dry substance under test.
5. Since the British Standard is not avail-
able in quantities sufficient for inclusion
in every assay run, it is recommended
that for routine use local standards should
be prepared and calibrated in terms ofthe
First British Standard.
AVAILABILITY OF THE FIRST BRITISH
STANDARD
Supplies of the Standard may be
requested from the Director of the
National Institute for Biological Standards
and Control, Holly Hill, Hampstead,
London, NW3 6RB, England. Limited
supplies of the Standard are available for
distribution outside the UK.
The development of the Standard has
been a collaborative project ofthe Chester
BeattyResearch InstituteandtheNational
Institute for Biological Standards and
Control. It is a pleasure to acknowledge
the very helpful discussions with many
colleagues, in particular Drs K. D.
Bagshawe, S. 0. Freedman, H. C. Good-
man, J.-P. Mach, Professor F. Martin, Drs
D. S. Rowe and C. W. Todd. Some of
these also supplied material for which we
were most grateful. The work was sup-
ported in part by grants from the World
Health Organisation and the Medical
Research Council.
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